Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a condition where stomach contents reflux causes troublesome symptoms like heartburn and regurgitation, GERD’s diagnosis often involves endoscopy and reflux monitoring, especially for patients unresponsive to initial treatments. Advanced diagnostic tools such as pH or impedance-pH monitoring and high-resolution esophageal manometry help clinicians confirm GERD and assess for surgical suitability in more severe cases. Evolving treatments include tailored use of proton pump inhibitors (PPIs), novel medical therapies, and endoscopic procedures. Explore the full article for a comprehensive review of diagnostic and management strategies that are helping clinicians better address this pervasive condition.
Trending
- Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinical Research (Business Wire)
- Private Equity vs. Independent Medicine: When Wall Street Enters the Exam Room (Working Healthcare – the Podcast Fixing Healthcare)
- Artificial Intelligence Is Not the End of the Physician (JAMA)
- Charted: The most (and least) burned out physician specialties (Advisory Board)
- Growth, practice value and mergers: A strategic guide for physicians (Medical Economics)
- The potential ‘litigation wave’ headed for GI (Becker’s GI & Endoscopy)
- Groundbreaking new study shows real-time AI platform better at diagnosing cancer than biopsy (UMass Chan Medical School)
- Investigational endoscopic therapy maintains weight after GLP-1 discontinuation (GI & Hepatology News)
